Session Information

  • WCLC 2021

    2021 World Conference on Lung Cancer

    Conference Program for 2021 the World Conference on Lung Cancer

    Presentation Date(s):  
    • September 8 - 14, 2021
    • Total Presentations: 1107

    All times listed are in Mountain Time MDT (UTC-6:00)

    PL - Plenary
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    WS - Workshops
    IS - Industry Symposium
    MTE - Meet the Expert
    BEDG - Brain Exchange Discussion Groups

Filter Results:

Show Only CME Accredited Sessions

  • +

    ES06 - Immuno-Biology and Novel Immunotherapeutics in Lung Cancer*

    • 09:45 - 10:20
    • 9/10/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
    *Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.
    • +

      ES06.01 - Task Force in Methodology: Developing New Trials with Immunotherapeutic Agents

      09:45 - 09:47  |  Presenter: Rosalyn Juergens

      • Abstract

      No abstract available for this presentation

    • +

      ES06.02 - Bi-Specific Agents

      09:47 - 09:49  |  Presenter: Taofeek Owonikoko

      • Abstract

      No abstract available for this presentation

    • +

      ES06.03 - "Not Just Another irAE" - Identification and Management of Immunotoxicities of Bispecifics and CAR-T

      09:49 - 09:51  |  Presenter: Melissa Johnson

      • Abstract

      No abstract available for this presentation

    • +

      ES06.04 - Intra-tumoral Immunotherapy

      09:51 - 09:53  |  Presenter: Stephane Champiat

      • Abstract

      No abstract available for this presentation

    • +

      ES06.05 - Approach to Chemotherapy for Oncogene-driven Cancers: Known Barriers and Future Promise

      09:53 - 09:55  |  Presenter: Noemi Reguart

      • Abstract

      No abstract available for this presentation

    • +

      ES06.06 - Live Discussion with Speakers

      09:55 - 10:20

      • Abstract

      No abstract available for this presentation

  • +

    ES07 - Grief and Loss in Palliative Care*

    • 09:45 - 10:20
    • 9/10/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Palliative and Supportive Care
    *Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.
    • +

      ES07.01 - Grief and Loss for the Patient

      09:45 - 09:47  |  Presenter: Celia Marston

      • Abstract

      No abstract available for this presentation

    • +

      ES07.02 - Non-pharmacologic Interventions for Physical Symptoms

      09:47 - 09:49  |  Presenter: Alex Molassiotis

      • Abstract

      No abstract available for this presentation

    • +

      ES07.03 - Psychosocial Interventions for Patients

      09:49 - 09:51  |  Presenter: Gary Rodin

      • Abstract

      No abstract available for this presentation

    • +

      ES07.04 - Communication in Palliative Care Settings

      09:51 - 09:53  |  Presenter: Rachelle Bernacki

      • Abstract

      No abstract available for this presentation

    • +

      ES07.05 - Grief and Loss for Clinicians and Clinician Self-care

      09:53 - 09:55  |  Presenter: Sonia Patricia Oyola

      • Abstract

      No abstract available for this presentation

    • +

      ES07.06 - Live Discussion with Speakers

      09:55 - 10:20

      • Abstract

      No abstract available for this presentation

  • +

    ES08 - What has COVID-19 Taught Us About Improving Management of Treatment for Patients with Lung Cancer*

    • 10:30 - 11:05
    • 9/10/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Management of Lung Cancer in the Era of COVID-19
    *Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.
    • +

      ES08.01 - COVID-19 Vaccines

      10:30 - 10:32  |  Presenter: Anne-Marie Dingemans

      • Abstract

      No abstract available for this presentation

    • +

      ES08.02 - What has COVID-19 Taught Us About Improving Management of Treatment for Patients with Lung Cancer

      10:32 - 10:34  |  Presenter: Gilberto Lopes

      • Abstract

      No abstract available for this presentation

    • +

      ES08.03 - Long-Term Outcomes

      10:34 - 10:36  |  Presenter: Annalisa Trama

      • Abstract

      No abstract available for this presentation

    • +

      ES08.04 - COVID-19 in Lower and Middle-Income Countries

      10:36 - 10:38  |  Presenter: Luis Corrales

      • Abstract

      No abstract available for this presentation

    • +

      ES08.05 - Live Discussion with Speakers

      10:38 - 11:05

      • Abstract

      No abstract available for this presentation

  • +

    ES09 - Pathology Assessment and Biomarker Testing: Implications of and for Adjuvant and Neoadjuvant Therapy*

    • 10:30 - 11:05
    • 9/10/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
    *Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.
    • +

      ES09.01 - Adjuvant and Neoadjuvant Therapy for NSCLC – Current and Future Perspectives

      10:30 - 10:32  |  Presenter: Daniel Tan

      • Abstract

      No abstract available for this presentation

    • +

      ES09.02 - Pathological Assessment Following Neoadjuvant Therapy: Challenges and Pitfalls

      10:32 - 10:34  |  Presenter: Sanja Dacic

      • Abstract

      No abstract available for this presentation

    • +

      ES09.03 - The Role of Biomarkers for Immunotherapy in the Adjuvant and Neoadjuvant Setting

      10:34 - 10:36  |  Presenter: Francois Ghiringhelli

      • Abstract

      Loading...

    • +

      ES09.04 - The Role of Biomarkers for Targeted Therapy in the Adjuvant and Neoadjuvant Setting

      10:36 - 10:38  |  Presenter: Fernando Lopez-Rios

      • Abstract

      No abstract available for this presentation

    • +

      ES09.05 - Facilitating Biomarker Discovery in the Adjuvant and Neoadjuvant Setting

      10:38 - 10:40  |  Presenter: Janis M Taube

      • Abstract

      No abstract available for this presentation

    • +

      ES09.06 - Tobacco Moment: The Criticality of Development of a Validated Tobacco Use Measurement Tool in Clinical Trials (Captured, Considered in Clinical Endpoints and Final Analysis)

      10:40 - 10:43  |  Presenter: Carolyn Dresler

      • Abstract

      No abstract available for this presentation

    • +

      ES09.07 - Live Discussion with Speakers

      10:43 - 11:05

      • Abstract

      No abstract available for this presentation

  • +

    ES10 - Optimizing Clinical Outcomes in Lung Cancer: The Value of Tobacco Cessation*

    • 11:15 - 11:50
    • 9/10/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Risk Reduction and Tobacco Control
    *Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.
    • +

      ES10.01 - Biologic and Translational Considerations of Tobacco Use Related to Therapeutic Outcomes

      11:15 - 11:17  |  Presenter: Graham Warren

      • Abstract

      No abstract available for this presentation

    • +

      ES10.03 - Impact of Smoking on Clinical Outcomes of Radiotherapy

      11:17 - 11:19  |  Presenter: Jacek Jassem

      • Abstract

      No abstract available for this presentation

    • +

      ES10.04 - Smoking and Cancer Clinical Trials

      11:19 - 11:21  |  Presenter: Bill Kenneth Evans

      • Abstract

      No abstract available for this presentation

    • +

      ES10.05 - Tobacco Dependence Treatment Guideline Update (American Thoracic Society Tobacco Treatment Guidelines released in 2020)

      11:21 - 11:24  |  Presenter: Frank Leone

      • Abstract

      No abstract available for this presentation

    • +

      ES10.06 - Live Discussion with Speakers

      11:24 - 11:50

      • Abstract

      No abstract available for this presentation

  • +

    ES11 - Small Cell Lung Cancer: Recent Preclinical Advances and Emerging Approaches to Therapy*

    • 11:15 - 11:50
    • 9/10/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Small Cell Lung Cancer/ NET
    *Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.
    • +

      ES11.01 - SCLC Subgroups and Their Potential Clinical Significance

      11:15 - 11:17  |  Presenter: Carl Gay

      • Abstract

      No abstract available for this presentation

    • +

      ES11.02 - Advances in Thoracic Radiation in SCLC

      11:17 - 11:19  |  Presenter: Bjørn Henning Grønberg

      • Abstract

      Loading...

    • +

      ES11.03 - Emerging Strategies in ES-SCLC in the Frontline

      11:19 - 11:21  |  Presenter: Qing Zhou

      • Abstract

      Loading...

    • +

      ES11.04 - Treatment Options for Second-line and Beyond in ES-SCLC

      11:21 - 11:23  |  Presenter: Victoria Lai

      • Abstract

      No abstract available for this presentation

    • +

      ES11.05 - Mechanisms of Resistance in SCLC

      11:23 - 11:25  |  Presenter: Lauren Averett Byers

      • Abstract

      No abstract available for this presentation

    • +

      ES11.06 - Live Discussion with Speakers

      11:25 - 11:50

      • Abstract

      No abstract available for this presentation

  • +

    BEDG01 - Meet the Nurse and Allied Health Committee

    • 12:00 - 13:00
    • 9/10/2021
    • Location: Brain Exchange Lounge
    • Not for CME Credit
    • Type: Brain Exchange Discussion Groups
    • Track: N.A.
    • +

      BEDG01.01 - Join the IASLC Nurse and Allied Health Committee for an Interactive Discussion about How to Build Your Career, Finding and Being a Good Mentor, Best Practices for the Field, Why Being Involved in IASLC Helped Their Careers, and So Much More

      12:00 - 13:00  |  Presenter: Morten Quist, Melissa Jane Culligan, Csaba Laszlo Degi, Michelle Turner

      • Abstract

      No abstract available for this presentation

  • +

    BEDG02 - Lung Ambition Alliance with AstraZeneca - Accelerating the Early Diagnosis of Lung Cancer at Local Level

    • 12:00 - 13:00
    • 9/10/2021
    • Location: Brain Exchange Lounge
    • Not for CME Credit
    • Type: Brain Exchange Discussion Groups
    • Track: N.A.
    • +

      BEDG02.01 - Welcome, Introductions and Session Overview

      12:00 - 12:00

      • Abstract

      No abstract available for this presentation

    • +

      BEDG02.02 - Time for Screening of Lung Cancer is Now

      12:00 - 12:00

      • Abstract

      No abstract available for this presentation

    • +

      BEDG02.03 - Challenges in LCS: How to Overcome Them

      12:00 - 12:00

      • Abstract

      No abstract available for this presentation

    • +

      BEDG02.04 - IPN Detection as a Complementary Strategy

      12:00 - 12:00

      • Abstract

      No abstract available for this presentation

    • +

      BEDG02.05 - Potential of AI in Early Lung Cancer Detection

      12:00 - 12:00

      • Abstract

      No abstract available for this presentation

    • +

      BEDG02.06 - Case Studies/Best Practices

      12:00 - 12:00

      • Abstract

      No abstract available for this presentation

    • +

      BEDG02.07 - Discussion/Q&A

      12:00 - 12:00

      • Abstract

      No abstract available for this presentation

  • +

    BEDG03 - Sip and Chat with the FDA

    • 12:00 - 13:00
    • 9/10/2021
    • Location: Brain Exchange Lounge
    • Not for CME Credit
    • Type: Brain Exchange Discussion Groups
    • Track: N.A.
  • +

    BEDG04 - Brain Exchange Session by AstraZeneca: 'Defining Cure’ in Stage III Unresectable NSCLC. Management to Long Term Survivors

    • 12:00 - 13:00
    • 9/10/2021
    • Location: Brain Exchange Lounge
    • Not for CME Credit
    • Type: Brain Exchange Discussion Groups
    • Track: N.A.
    • +

      BEDG04.01 - Defining “Cure” in Long Term Survivors in Early Stage Lung Cancer. Current Definition of Cure in NSCLC Clinical Practice

      12:00 - 12:00

      • Abstract

      No abstract available for this presentation

    • +

      BEDG04.02 - Identification and Management/Surveillance of Patients with Early Stage Who Achieve Long-Term Survival

      12:00 - 12:00

      • Abstract

      No abstract available for this presentation